Rhumbline Advisers Surmodics Inc Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Surmodics Inc stock. As of the latest transaction made, Rhumbline Advisers holds 19,389 shares of SRDX stock, worth $769,355. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,389
Previous 20,999 7.67%
Holding current value
$769,355
Previous $882,000 14.85%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$38.47 - $42.24 $61,936 - $68,006
-1,610 Reduced 7.67%
19,389 $751,000
Q2 2024

Aug 01, 2024
BUY
$25.39 - $42.1 $62,535 - $103,692
2,463 Added 13.29%
20,999 $882,000
Q1 2024

May 09, 2024
BUY
$27.44 - $35.56 $19,564 - $25,354
713 Added 4.0%
18,536 $543,000
Q4 2023

Feb 08, 2024
SELL
$28.47 - $38.49 $6,491 - $8,775
-228 Reduced 1.26%
17,823 $647,000
Q3 2023

Nov 09, 2023
SELL
$28.28 - $38.36 $1,979 - $2,685
-70 Reduced 0.39%
18,051 $579,000
Q2 2023

Aug 08, 2023
BUY
$17.67 - $31.31 $3,869 - $6,856
219 Added 1.22%
18,121 $567,000
Q1 2023

May 11, 2023
SELL
$17.13 - $38.52 $365,177 - $821,169
-21,318 Reduced 54.35%
17,902 $408,000
Q4 2022

Feb 14, 2023
BUY
$29.44 - $37.31 $24,641 - $31,228
837 Added 2.18%
39,220 $1.34 Million
Q3 2022

Nov 10, 2022
BUY
$28.84 - $38.92 $35,905 - $48,455
1,245 Added 3.35%
38,383 $1.17 Million
Q2 2022

Aug 11, 2022
BUY
$33.25 - $45.11 $10,374 - $14,074
312 Added 0.85%
37,138 $1.38 Million
Q1 2022

May 12, 2022
BUY
$40.68 - $49.72 $64,315 - $78,607
1,581 Added 4.49%
36,826 $1.67 Million
Q4 2021

Feb 10, 2022
SELL
$43.21 - $57.6 $11,018 - $14,688
-255 Reduced 0.72%
35,245 $1.7 Million
Q3 2021

Nov 12, 2021
SELL
$52.8 - $60.32 $290,875 - $332,302
-5,509 Reduced 13.43%
35,500 $1.97 Million
Q2 2021

Aug 05, 2021
SELL
$51.29 - $59.15 $51,443 - $59,327
-1,003 Reduced 2.39%
41,009 $2.23 Million
Q1 2021

May 06, 2021
BUY
$42.18 - $56.07 $29,610 - $39,361
702 Added 1.7%
42,012 $2.36 Million
Q4 2020

Feb 10, 2021
BUY
$35.18 - $43.52 $102,268 - $126,512
2,907 Added 7.57%
41,310 $1.8 Million
Q3 2020

Nov 12, 2020
SELL
$37.98 - $48.72 $62,249 - $79,852
-1,639 Reduced 4.09%
38,403 $1.49 Million
Q2 2020

Aug 13, 2020
SELL
$31.07 - $44.74 $272,452 - $392,325
-8,769 Reduced 17.97%
40,042 $1.73 Million
Q1 2020

May 06, 2020
SELL
$22.46 - $42.24 $138,982 - $261,381
-6,188 Reduced 11.25%
48,811 $1.63 Million
Q4 2019

Feb 05, 2020
BUY
$39.01 - $47.51 $99,397 - $121,055
2,548 Added 4.86%
54,999 $2.28 Million
Q3 2019

Oct 23, 2019
BUY
$38.66 - $47.41 $16,082 - $19,722
416 Added 0.8%
52,451 $2.4 Million
Q2 2019

Aug 14, 2019
BUY
$38.23 - $47.43 $406,423 - $504,228
10,631 Added 25.68%
52,035 $2.25 Million
Q1 2019

May 01, 2019
SELL
$41.26 - $58.35 $310,646 - $439,317
-7,529 Reduced 15.39%
41,404 $1.8 Million
Q4 2018

Jan 31, 2019
BUY
$44.93 - $73.38 $746,736 - $1.22 Million
16,620 Added 51.43%
48,933 $2.31 Million
Q3 2018

Nov 07, 2018
SELL
$56.85 - $80.35 $19,499 - $27,560
-343 Reduced 1.05%
32,313 $2.41 Million
Q2 2018

Aug 06, 2018
BUY
$35.85 - $57.05 $29,755 - $47,351
830 Added 2.61%
32,656 $1.8 Million
Q1 2018

May 02, 2018
BUY
$27.0 - $38.5 $17,766 - $25,333
658 Added 2.11%
31,826 $1.21 Million
Q4 2017

Feb 09, 2018
BUY
$28.0 - $33.2 $101,220 - $120,018
3,615 Added 13.12%
31,168 $873,000
Q3 2017

Nov 06, 2017
BUY
$24.5 - $31.1 $675,048 - $856,898
27,553
27,553 $854,000

Others Institutions Holding SRDX

# of Institutions
126
Shares Held
11.8M
Call Options Held
1.4K
Put Options Held
8.6K
View Full List

About SURMODICS INC

SRDX Quotes by TradingView
  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $556M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email